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b St George’s, University of London, London, UK1. Introduction
Auscultation of the fetal heart rate (FHR) became part of routine
intrapartum care inmany countries during the 19th century [1], and re-
mains an important form of fetal surveillance, particularly in low-risk
pregnancies and in low-resource countries. Several technical break-
throughs that occurred in the 20th century led to the development of
different formsof continuous electronicmonitoring of the FHR anduter-
ine contractions in the 1950s and early 1960s, and to the commerciali-
zation of the technology known as cardiotocography (CTG) in the late
1960s [2]. Cardiotocography (kardia meaning heart, tokos meaning
labor/childbirth) is the term that best describes the continuous moni-
toring of the FHR and uterine contractions, but other designations
such as electronic fetal monitoring are used in some countries. Fetal
scalp blood sampling was introduced into clinical practice at around
the same time as CTG [3], and other methods for intrapartum fetal sur-
veillance were subsequently developed, including continuous fetal pH
monitoring, fetal lactate measurement, fetal pulse oximetry, and ST
waveform analysis—and some of these were successfully established.
The FIGO Consensus Guidelines on Intrapartum Fetal Monitoring will
focus on the clinical application of currently available methods for
intrapartum fetal monitoring.☆ Developed by the FIGO Safe Motherhood and Newborn Health Committee;
coordinated by Diogo Ayres-de-Campos.
★ The views expressed in this document reﬂect the opinion of the individuals and not
necessarily those of the institutions that they represent.
1 Consensus panel: Daniel Surbek (Switzerland⁎), Gabriela Caracostea (Romania⁎), Yves
Jacquemyn (Belgium⁎), Susana Santo (Portugal⁎), Lennart Nordström (Sweden⁎), Tullia
Todros (Italy⁎), Branka Yli (Norway⁎), George Farmakidis (Greece⁎), Sandor Valent
(Hungary⁎), Bruno Carbonne (France⁎), Kati Ojala (Finland⁎), José Luis Bartha (Spain⁎),
Joscha Reinhard (Germany⁎), Anneke Kwee (Netherlands⁎), Ehigha Enabudoso
(Nigeria⁎), Fadi Mirza (Lebanon⁎), Tak Yeung Leung (Hong Kong⁎), Ramon Reyles
(Philippines⁎), Park in Yang (South Korea⁎), Henry Murray (Australia and New
Zealand⁎), Yuen Tannirandorn (Thailand⁎), Krishna Kumar (Malaysia⁎), Taghreed
Alhaidari (Iraq⁎), Tomoaki Ikeda (Japan⁎), Ferdousi Begum (Bangladesh⁎), Jorge Carvajal
(Chile⁎), José Teppa (Venezuela⁎), Renato Sá (Brazil⁎), Lawrence Devoe (USA⁎⁎), Gerard
Visser (Netherlands⁎⁎), Richard Paul (USA⁎⁎), Barry Schifrin (USA⁎⁎), Julian Parer
(USA⁎⁎), Philip Steer (UK⁎⁎), Vincenzo Berghella (USA⁎⁎), Isis Amer-Wahlin (Sweden⁎⁎),
Susanna Timonen (Finland⁎⁎), Austin Ugwumadu (UK⁎⁎), João Bernardes (Portugal⁎⁎),
Justo Alonso (Uruguay⁎⁎), Catherine Spong (USA⁎⁎), Edwin Chandraharan (UK⁎⁎).
⁎Nominated by FIGO associated national society; ⁎⁎ Invited by FIGO based on literature
search.
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convened an expert consensus meeting in Switzerland to produce the
“Guidelines for the use of Fetal Monitoring,” which were approved by
FIGO's Executive Board in 1986 and published in 1987 [3]. These guide-
lines were an important landmark in the history of FHRmonitoring be-
cause they constituted the ﬁrst wide-scale agreement on essential
aspects of CTGmonitoring, such as terminology, indications, acquisition
techniques, and interpretation. Notwithstanding their decisive contri-
bution to the ﬁeld of fetal monitoring, with the passage of time, some
shortcomings have become evident [4], and the document has naturally
become outdated.
The present FIGO Consensus Guidelines were developed under
FIGO’s Safe Motherhood and Newborn Health Committee. In February
2013, all national member societies of FIGO were contacted by email
and asked to appoint one expert in this ﬁeld with a wide knowledge
of the fetal monitoring scientiﬁc literature, good written and spoken
English, and who would be available to provide written feedback by
email in less than 15days. ByMay2013, 33 experts had been nominated
by national scientiﬁc societies. A literature search was then conducted
to identify a further list of experts who had published major clinical
research in the ﬁeld. Thirteen additional experts were invited according
to this criterion. A geographical representation of the members of the
consensus panel is presented in Fig. 1.
The American College of Obstetricians and Gynecologists and the
Royal College of Obstetricians and Gynaecologists were contacted
in December 2012 for each to appoint one member of the writing
committee for the cardiotocography chapter [5], and the International
Confederation of Midwives was contacted in July 2013 to nominate
the authors of the intermittent auscultation chapter [6].
The consensus process started in October 2013, and included three
rounds for each chapter. Each round started with a draft version that
was sent by email to the panel members, followed by written feedback
from the panel within a time frame of three weeks. The received com-
ments were considered by the authors and a revised manuscript was
produced for the next round. After the three-round process was com-
plete, the members of the panel were asked to read the ﬁnal version
and to give written consent for their name to be included in the panel
list for that chapter. The consensus process for the four chapters was
concluded in March 2015.
The purpose of these revised consensus guidelines is to update the
existing ones, expand their scope to include all currently availableynecology and Obstetrics.
Fig. 1. Geographical representation of the members of the FIGO consensus panel.
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cessible to all healthcare professionals, independently of their previous
expertise in the subject. The ultimate goal is to contribute to the im-
provement of intrapartum fetal monitoring throughout the world,
thus reducing the burden of perinatalmortality and long-term sequelae,
while at the same time avoiding unnecessary obstetric intervention.
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